CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Lonza Group Ltd - LONN CFD

502.3
0.12%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 2.0
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0236 %
Charges from borrowed part ($-0.94)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0236%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0236 %
Charges from borrowed part ($-0.94)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0208%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency CHF
Margin 20%
Stock exchange Switzerland
Commission on trade 0%

*Information provided by Capital.com

Lonza Group AG ESG Risk Ratings

High Medium Low Negligible

‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

More ESG coverage

Key Stats
Prev. Close* 501.5
Open* 496.8
1-Year Change* -25.03%
Day's Range* 496.8 - 496.8
52 wk Range 436.8-771.6
Average Volume (10 days) 0.16916
Average Volume (3 months) 3.69505
Market Cap 36981.2
P/E Ratio 40.6674
Shares Outstanding 74189100
Revenue 5849
EPS 12.2113
Dividend (Yield %) 0.60411
Beta 1.08204
Next Earnings Date Jan 24, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 30, 2022 502.3 8.3 1.68% 494.0 502.5 494.0
Jun 29, 2022 501.5 -0.8 -0.16% 502.3 505.1 490.0
Jun 28, 2022 511.5 -0.8 -0.16% 512.3 514.7 505.3
Jun 27, 2022 512.1 3.6 0.71% 508.5 517.5 506.5
Jun 24, 2022 511.5 16.7 3.38% 494.8 514.3 491.9
Jun 23, 2022 486.9 -1.4 -0.29% 488.3 488.3 479.7
Jun 22, 2022 490.4 10.4 2.17% 480.0 491.0 474.9
Jun 21, 2022 488.4 4.2 0.87% 484.2 496.4 484.2
Jun 20, 2022 486.6 -9.1 -1.84% 495.7 497.1 485.7
Jun 17, 2022 493.5 11.7 2.43% 481.8 503.9 481.8
Jun 16, 2022 487.0 -21.9 -4.30% 508.9 511.5 483.1
Jun 15, 2022 512.9 9.4 1.87% 503.5 514.3 503.3
Jun 14, 2022 503.1 -16.6 -3.19% 519.7 519.7 497.5
Jun 13, 2022 519.9 -21.7 -4.01% 541.6 541.6 519.9
Jun 10, 2022 542.1 -7.9 -1.44% 550.0 553.2 538.5
Jun 9, 2022 556.0 -8.0 -1.42% 564.0 569.0 555.8
Jun 8, 2022 573.4 14.4 2.58% 559.0 576.6 559.0
Jun 7, 2022 567.0 6.6 1.18% 560.4 569.2 559.2
Jun 3, 2022 564.0 -7.0 -1.23% 571.0 576.2 562.6
Jun 2, 2022 570.6 11.2 2.00% 559.4 570.8 559.4

Lonza Group Ltd Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 4132 4548 5542 4207 4508 5409
Revenue 4132 4548 5542 4207 4508 5409
Cost of Revenue, Total 2731 2797 3402 2429 2645 3299
Gross Profit 1401 1751 2140 1778 1863 2110
Total Operating Expense 3646 3875 4700 3382 3607 4558
Selling/General/Admin. Expenses, Total 701 724 850 608 648 711
Research & Development 84 95 110 75 78 90
Depreciation / Amortization 58 126 193 193 186 175
Interest Expense (Income) - Net Operating -3 8 12 5 -1 0
Unusual Expense (Income) 51 108 127 91 72 -24
Other Operating Expenses, Total 24 17 6 -19 -21 307
Operating Income 486 673 842 825 901 851
Interest Income (Expense), Net Non-Operating -104 -125 -26 -99 -94 -83
Other, Net -9 -13 -9 -7 -4 -8
Net Income Before Taxes 373 535 807 719 803 760
Net Income After Taxes 301 666 659 648 732 677
Minority Interest 0 -2 -4 -1 -2 -3
Net Income Before Extra. Items 301 664 655 647 730 674
Net Income 301 707 559 645 869 2944
Income Available to Common Excl. Extra. Items 301 664 655 647 730 674
Income Available to Common Incl. Extra. Items 301 707 559 645 869 2944
Dilution Adjustment 0 0 0
Diluted Net Income 301 707 559 645 869 2944
Diluted Weighted Average Shares 57.0727 68.4602 74.7232 74.5648 74.7091 74.4901
Diluted EPS Excluding Extraordinary Items 5.27398 9.69906 8.76569 8.67702 9.77124 9.04818
Dividends per Share - Common Stock Primary Issue 2.5473 2.75 2.75 2.75 3 3
Diluted Normalized EPS 6.56066 10.7245 10.1536 9.77692 10.6498 12.4205
Total Extraordinary Items 43 -96 -2 139 2270
Q4 2019 Q2 2020 Q4 2020 Q2 2021 Q4 2021
Total revenue 1231 2243 1434 2542 2867
Revenue 1231 2243 1434 2542 2867
Cost of Revenue, Total 616 1269 809 1499 1800
Gross Profit 615 974 625 1043 1067
Total Operating Expense 915 1712 1151 2225 2333
Other Operating Expenses, Total 299 443 342 726 533
Operating Income 316 531 283 317 534
Interest Income (Expense), Net Non-Operating -3 -42 -17 -17 -49
Other, Net -36 -3 -27 -4 -21
Net Income Before Taxes 277 486 239 296 464
Net Income After Taxes 255 442 254 263 414
Minority Interest 0 -1 -1 -2 -1
Net Income Before Extra. Items 255 441 253 261 413
Total Extraordinary Items 91 36 139 58 2212
Net Income 346 477 392 319 2625
Income Available to Common Excl. Extra. Items 255 441 253 261 413
Income Available to Common Incl. Extra. Items 346 477 392 319 2625
Diluted Net Income 346 477 392 319 2625
Diluted Weighted Average Shares 74.6022 74.6479 74.7933 74.5327 74.4475
Diluted EPS Excluding Extraordinary Items 3.41813 5.90774 3.38266 3.50182 5.54753
Dividends per Share - Common Stock Primary Issue 2.75 0 3 0 3
Diluted Normalized EPS 3.82534 5.89555 3.77373 6.86357 5.75128
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 2065 2733 3514 3040 4801 5955
Cash and Short Term Investments 274 479 461 505 495 3184
Cash 222 458 401 429 345 954
Cash & Equivalents 52 21 60 76 150 628
Total Receivables, Net 701 972 775 846 834 1164
Accounts Receivable - Trade, Net 612 825 692 759 715 1055
Total Inventory 897 1177 1250 1392 1136 1501
Prepaid Expenses 85 93 187 247 280 65
Other Current Assets, Total 108 12 841 50 2056 41
Total Assets 6828 13831 13921 13841 14429 16459
Property/Plant/Equipment, Total - Net 2412 3198 3152 3817 3591 4694
Property/Plant/Equipment, Total - Gross 6058 7113 7170 8094 6504 7963
Accumulated Depreciation, Total -3646 -3915 -4018 -4277 -2913 -3269
Goodwill, Net 1287 4002 3748 3651 3072 2986
Intangibles, Net 968 3701 3312 3073 2640 2454
Long Term Investments 31 36 22 85 89 104
Note Receivable - Long Term 1 20 59 72 162 177
Other Long Term Assets, Total 64 141 114 103 74 89
Total Current Liabilities 1632 2173 2380 2675 3097 2370
Accounts Payable 284 400 428 453 308 483
Accrued Expenses 561 637 803 863 440 509
Notes Payable/Short Term Debt 68 119 103 6 6 0
Current Port. of LT Debt/Capital Leases 221 397 338 768 814 219
Other Current Liabilities, Total 498 620 708 585 1529 1159
Total Liabilities 4473 7698 7703 7347 7614 6709
Total Long Term Debt 1571 3730 3621 2766 2994 2530
Long Term Debt 1565 3719 3611 2766 2784 2234
Capital Lease Obligations 6 11 10 0 210 296
Deferred Income Tax 329 760 711 630 581 540
Other Liabilities, Total 941 987 919 1205 873 1196
Total Equity 2355 6133 6218 6494 6815 9750
Common Stock 53 74 74 74 74 74
Additional Paid-In Capital 311 3314 3314 3314 2804 2693
Retained Earnings (Accumulated Deficit) 2565 3139 3468 3881 4985 7975
Treasury Stock - Common -10 -59 -71 -51 -100 -177
Other Equity, Total -564 -335 -567 -724 -948 -815
Total Liabilities & Shareholders’ Equity 6828 13831 13921 13841 14429 16459
Total Common Shares Outstanding 56.9921 74.0169 74.0236 74.2888 74.2831 74.1891
Minority Interest 48 72 71 69 73
Short Term Investments 1602
Dec 2019 Jun 2020 Dec 2020 Jun 2021 Dec 2021
Total Current Assets 3040 3128 4801 5030 5955
Cash and Short Term Investments 505 557 495 501 3184
Cash & Equivalents 505 557 495 501 1582
Other Current Assets, Total 2535 2571 2019 4529 0
Total Assets 13841 13947 14429 15161 16459
Other Long Term Assets, Total 10801 10819 325 10131 370
Total Current Liabilities 2675 1936 3097 3109 2370
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 774 330 796 858 169
Other Current Liabilities, Total 1901 1606 1993 2251 1718
Total Liabilities 7347 7475 7614 7894 6709
Total Long Term Debt 2766 3486 2784 2789 2234
Long Term Debt 2766 3486 2784 2789 2234
Minority Interest 71 69 69 73 73
Other Liabilities, Total 1835 1984 1083 1923 1492
Total Equity 6494 6472 6815 7267 9750
Common Stock 74 74 74 74 74
Additional Paid-In Capital 3314 3314 2804 2693 2693
Retained Earnings (Accumulated Deficit) 3881 3989 4985 5360 7975
Treasury Stock - Common -51 -6 -100 -84 -177
Other Equity, Total -724 -899 -948 -776 -815
Total Liabilities & Shareholders’ Equity 13841 13947 14429 15161 16459
Total Common Shares Outstanding 74.2888 74.2888 74.2831 74.2831 74.1891
Total Receivables, Net 747 956
Accounts Receivable - Trade, Net 715 928
Total Inventory 1136 1501
Prepaid Expenses 404 314
Property/Plant/Equipment, Total - Net 3591 4694
Goodwill, Net 3072 2986
Intangibles, Net 2640 2454
Accounts Payable 308 483
Deferred Income Tax 581 540
Short Term Investments 1602
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 301 709 563 646 871 2947
Cash From Operating Activities 752 841 1082 977 1130 1217
Cash From Operating Activities 249 285 333 351 340 347
Amortization 58 126 193 193 186 175
Non-Cash Items 346 61 415 420 317 -1745
Cash Taxes Paid 54 102 143 137 150 166
Cash Interest Paid 63 62 82 80 49 63
Changes in Working Capital -202 -340 -422 -633 -584 -507
Cash From Investing Activities -601 -3748 -652 -285 -1089 1021
Capital Expenditures -366 -451 -575 -786 -973 -1341
Other Investing Cash Flow Items, Total -235 -3297 -77 501 -116 2362
Cash From Financing Activities -151 3199 -413 -663 93 -1283
Financing Cash Flow Items 65 -43 28 58 314 345
Total Cash Dividends Paid -131 -159 -205 -204 -204 -223
Issuance (Retirement) of Stock, Net 48 3055 -77 -47 -141 -174
Issuance (Retirement) of Debt, Net -133 346 -159 -470 124 -1231
Foreign Exchange Effects 1 -87 -14 -6 -20 8
Net Change in Cash 1 205 3 23 114 963
Dec 2019 Jun 2020 Dec 2020 Jun 2021 Dec 2021
Net income/Starting Line 646 478 871 321 2947
Cash From Operating Activities 977 430 1130 549 1217
Non-Cash Items 510 418 794 623 -1912
Changes in Working Capital -179 -466 -535 -395 182
Cash From Investing Activities -285 -491 -1089 -435 1021
Capital Expenditures -820 -416 -981 -516 -1341
Other Investing Cash Flow Items, Total 535 -75 -108 81 2362
Cash From Financing Activities -663 129 93 -201 -1283
Financing Cash Flow Items 58 85 314 132 345
Total Cash Dividends Paid -204 -206 -204 -223 -223
Issuance (Retirement) of Stock, Net -47 -46 -141 -81 -174
Issuance (Retirement) of Debt, Net -470 296 124 -29 -1231
Foreign Exchange Effects -6 -16 -20 13 8
Net Change in Cash 23 52 114 -74 963
Cash Taxes Paid 83 150 128
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 10.0402 7476826 112856 2022-10-04 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.7317 2034275 7712 2022-10-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.3638 1760295 44015 2021-12-31 LOW
UBS Asset Management (Switzerland) Investment Advisor 2.1876 1629098 33716 2022-10-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.7913 1333981 -4099 2022-10-31 LOW
Capital Research Global Investors Investment Advisor 1.7432 1298161 12612 2022-09-30 LOW
Credit Suisse Asset Management Investment Advisor/Hedge Fund 1.4806 1102581 11890 2022-10-31 LOW
Zürcher Kantonalbank (Asset Management) Bank and Trust 1.2764 950547 357 2022-10-31 LOW
Nuveen LLC Pension Fund 1.0724 798585 0 2022-10-31 LOW
BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.0094 751701 25167 2022-10-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 0.8481 631599 -2025 2022-10-31 LOW
Harding Loevner LP Investment Advisor 0.841 626306 0 2022-07-31 LOW
WCM Investment Management Investment Advisor 0.8037 598507 -26804 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 0.565 420783 -46558 2022-10-31 LOW
Allianz Global Investors GmbH Investment Advisor 0.5559 413974 408 2022-10-31 LOW
Invesco Advisers, Inc. Investment Advisor 0.5458 406452 11251 2022-10-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.539 401409 -333 2022-10-31 LOW
JPMorgan Asset Management U.K. Limited Investment Advisor/Hedge Fund 0.5151 383605 -5186 2022-10-31 LOW
J O Hambro Capital Management Limited Investment Advisor/Hedge Fund 0.5038 375149 -12341 2022-06-30 MED
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.4991 371665 -475 2022-10-31 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
480000+

Traders

75000+

Active clients monthly

$52000000+

Monthly investing volume

$34000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Lonza Company profile

About Lonza Group AG

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Lonza Group AG revenues increased 20% to SF5.41B. Net income before extraordinary items decreased 8% to SF674M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Equity Earnings -Before Taxes increase from SF4M to SF28M (expense), Effective G/L on Derivatives - Hedging increase from SF0K to SF13M (expense).

Equity composition

5/2017, Rights Issue, 2 new shares for every 7 shares held @ CHF136 (Factor: 1.07958).

Industry: Biotechnology & Medical Research (NEC)

Muenchensteinerstrasse 38
BASEL
BASEL-STADT 4002
CH

Income Statement

People also watch

Natural Gas

6.24 Price
+6.110% 1D Chg, %
Long position overnight fee 0.0600%
Short position overnight fee -0.0880%
Overnight fee time 22:00 (UTC)
Spread 0.006

BTC/USD

17,158.90 Price
-0.470% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

Oil - Crude

71.65 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0125%
Short position overnight fee -0.0013%
Overnight fee time 22:00 (UTC)
Spread 0.03

US100

11,547.10 Price
-0.700% 1D Chg, %
Long position overnight fee -0.0166%
Short position overnight fee 0.0059%
Overnight fee time 22:00 (UTC)
Spread 3.0

Still looking for a broker you can trust?

Join the 480.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading